Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
30
# OF OVERLAPPING
HOLDINGS
XBI
136
HOLDINGS
22%
ALSO IN CANC
CANC
53
HOLDINGS
58%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 1.7% | 7.2% | 1.7% |
|
EXELIXIS INC | 1.4% | 2.8% | 1.4% |
|
CELCUITY INC. | 1.4% | 3.7% | 1.4% |
|
NUVALENT, INC. CLASS A | 1.2% | 3.1% | 1.2% |
|
HALOZYME THERAPEUTICS INC | 1.2% | 1.2% | 1.2% |
XBI Overweight Relative to CANC
|
TRAVERE THERAPEUTICS, INC. | 1.7% |
|
TG THERAPEUTICS INC | 1.6% |
 |
ALKERMES PLC | 1.6% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 1.5% |
|
NEUROCRINE BIOSCIENCES INC | 1.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.4% |
|
KRYSTAL BIOTECH, INC. | 1.4% |
|
CYTOKINETICS INC | 1.4% |
|
SCHOLAR ROCK HOLDING CORP. | 1.3% |
|
APOGEE THERAPEUTICS, INC. | 1.3% |
XBI Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.5% |
|
ELI LILLY & CO | -4.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
NOVARTIS AG | -4.1% |
 |
ASTRAZENECA PLC | -3.5% |
|
MERCK & CO. INC. | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.3% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.0% |
|
IMMUNOME, INC. | -2.9% |
|
COGENT BIOSCIENCES INC | -2.8% |